Beximco Pharmaceuticals Ltd.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:10 |
Report Publication Announcement
Request of Extension to Publish Q1 Results
|
English | 11.2 KB | ||
| 2025-11-04 08:25 |
Regulatory Filings
Change of Name to Beximco Pharmaceuticals PLC.
|
English | 10.8 KB | ||
| 2025-10-27 16:53 |
Report Publication Announcement
Request of Extension to Publish Financial Results
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea
067630
South Korea
067630
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea
196300
South Korea
196300
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea
047920
South Korea
047920
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
South Korea
115450
South Korea
115450
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark
HLUN
Denmark
HLUN
South Korea
145020
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America
HUMA
United States of America
HUMA
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea
205470
South Korea
205470
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea
200670
South Korea
200670
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea
243070
South Korea
243070